CJC-1295 isn't stocked on pharmacy shelves in Samo or anywhere else for that matter — it's a research compound supplied via a dedicated online market. What this means for Samo researchers is that your location matters far less than your ability to assess COA data — and those verification methods are available to every researcher. Separating properly characterised CJC-1295 from the rest of the market comes down to three things: an HPLC chromatogram documenting ≥98% purity, mass spec data confirming the correct molecular weight, and a batch-specific endotoxin panel. The sections below cover what Samo researchers need to know about sourcing, verifying, and handling CJC-1295 for research purposes.
CJC-1295 Mechanisms Explained
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Samo researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
Where to Buy CJC-1295 — A Researcher's Guide
The most reliable path to quality CJC-1295 is starting with community forums — peptide forums track vendor quality over time that are more trustworthy than marketing materials. Endotoxin testing in the COA is non-negotiable for any injectable research use — endotoxins from microbial contamination can trigger severe inflammatory responses even at very low concentrations. For Samo researchers evaluating unfamiliar vendors: a test quantity before committing to research volumes before scaling up your order is the accepted approach among experienced researchers. For Samo researchers making a first CJC-1295 purchase: verify the vendor against this framework, begin with a small order, and confirm the COA batch number matches your received product before use.
Order CJC-1295 — ships to Samo
COA-verified · International tracking · Research grade
All use of CJC-1295 in Samo or anywhere is research use only — this compound is not approved for therapeutic human application, and all handling should adhere to research compound handling standards. Reconstitute CJC-1295 with bacteriostatic water at the concentration suited to your research design; a standard 5mg reconstituted in 2mL produces 2.5mg/mL — providing 25mcg per unit measured on a 100-unit syringe. Endotoxin testing in the CJC-1295 COA is not optional — gram-negative bacterial endotoxins can trigger severe inflammatory responses at very low concentrations, and no pricing advantage justifies skipping this verification. PubMed and related preprint servers provide the most complete literature coverage for CJC-1295 research; focus on peer-reviewed publications with documented compound quality over case reports or anecdotal evidence.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
